MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Parkinson’s Disease Risk Genotypes at the GPNMB Locus Associate with Extent of Post-mortem Lewy Pathology

    E. Brody, E. Suh, V. van Deerlin, J. Trojanowski, E. Lee, A. Chen-Plotkin (PHILADELPHIA, USA)

    Objective: To determine whether Parkinson’s disease (PD) risk genotypes at the GPNMB locus associate with distribution of Lewy pathology in brain samples from a spectrum…
  • 2024 International Congress

    Association of Impulse Control Disorder with GRIN2B Gene Polymorphisims in Parkinson Disease

    G. Memari, E. Erzurumluoglu, N. Durmaz Celik, S. özkan, S. Artan (Eskisehir, Turkey)

    Objective: The aim of this study was to investigate the effect of GRIN2B gene rs1806201 and rs7301328 polymorphisms on the development of Impulse Control Disorder…
  • 2024 International Congress

    Association of Liver Fibrosis with Motor Deficits in Parkinson’s Disease

    A. Zolin, H. Ooi, H. Sarva (New York, USA)

    Objective: To determine the impact of liver fibrosis on motor symptoms in Parkinson’s disease Background: Parkinson’s disease motor symptoms can vary with systemic illnesses [1,2].…
  • 2024 International Congress

    Maintaining Isometric Contraction in Parkinson’s Disease: Effect of PD-Medication on EMG Amplitude

    B. Afsharipour, F. Roy, M. Schindle, F. Ba, M. Gorassini, T. Sankar (Edmonton, Canada)

    Objective: To quantify muscle activity changes in PD with dopaminergic medication. Background: Parkinson's disease (PD) is characterized by motor symptoms that improve with dopaminergic medication.…
  • 2024 International Congress

    Predictive Accuracy of Baseline DaT-SPECT for Freezing of Gait at 5, 7, and 10-year Follow up in The PPMI Cohort

    J. Li, R. Rajmohan, J. Ruiz Tejeda, N. Phielipp (Irvine, USA)

    Objective: To see if segmentation models of baseline DaT-SPECT striatal binding ratios (SBR) will predict freezing of gait (FoG) in Parkinson’s Disease over a 5,…
  • 2024 International Congress

    Women with Parkinson’s disease: exploring the occurrence of hormone-related symptom fluctuations and associated care

    W. Kapelle, A. Oosterbaan, E. Stuart, H. Bogers, B. Bloem, M. Meinders, B. Post (Nijmegen, Netherlands)

    Objective: To explore the occurrence of hormone-related symptom fluctuations and associated care in women with Parkinson’s disease (PD). Background: Pre- and (peri)menopausal women with PD…
  • 2024 International Congress

    Longitudinal Gait Speed Analysis at Prodromal and Early Stage of Parkinson’s Disease

    S. Sambin, M. Houot, F. Khoury, G. Mangone, L-L. Mariani, I. Arnulf, S. Lehericy, M. Vidailhet, J-C. Corvol (Paris, France)

    Objective: We aimed at exploring gait speed (GS) as a potential biomarker of disease evolution in early stages of PD with three objectives. 1- To…
  • 2024 International Congress

    Vegetables and fruits to relieve constipation: Do Parkinson’s disease patients know them?

    K. Methawasin, A. Krittayasingh, P. Chonmaitree (Nakhon Nayok, Thailand)

    Objective: To compare the knowledge of vegetables and fruits for treating constipation between PD and non-PD patients with constipation. Background: Constipation is a common non-motor…
  • 2024 International Congress

    Preventing Medication Errors for Hospitalized People with Parkinson’s Disease – Results of Six Months of Proactive Intervention

    C. Piccinin, J. Yu, A. Brooks, V. Stepanyants, P. Clark, S. Shaffer, B. Sokola, K. Lewin, C. Sonneborn, O. Hogue, S. Sperling, H. Fernandez, W. Walter (Cleveland, USA)

    Objective: To determine whether a Parkinson’s disease (PD) Inpatient Program will prevent medication errors and ultimately improve the safety and quality of care for hospitalized…
  • 2024 International Congress

    Syllable-based speech characteristics as potential biomarker for differential diagnosis of Parkinson’s disease, multiple system atrophy, and cerebellar ataxia

    B. Jin, H. Kim, K. Woo, J. Shin (Seoul, Republic of Korea)

    Objective: To analyze syllable-based speech characteristics in patients with Parkinson’s disease (PD), multiple system atrophy (MSA), and cerebellar ataxia (CA) to determine if there is…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #23660 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley